SSCM
NEO icon

Sovereign's Capital Management’s NeoGenomics NEO Stock Holding History

Sovereign's Capital Management’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-40,974
Closed -$316K – 80
2025
Q3 		$316K Buy
40,974
+286
+0.7% +$2K 0.17% 75
2025
Q2 		$297K Buy
40,688
+6,592
+19% +$53.2K 0.16% 77
2025
Q1 		$324K Buy
34,096
+4,379
+15% +$54.7K 0.19% 80
2024
Q4 		$490K Buy
+29,717
New +$462K 0.31% 66

Other funds holding NEO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
GF
Greenhouse Funds Baltimore, Maryland $1.96B AUM 36.47% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Sovereign's Capital Management's NEO Position: Q4 2025 in Review

Sovereign's Capital Management sold out of NeoGenomics (NEO) in Q4 2025, closing a stake of 40,974 shares — an estimated $316K sold.

Sovereign's Capital Management first reported a position in NEO in Q4 2024 and held it in 4 quarters. The position peaked at $490K in Q4 2024. 256 funds tracked by Wall St. Rank hold NEO as of Q4 2025.

  • Sovereign's Capital Management reported no remaining NeoGenomics position as of Q4 2025 after selling out during the quarter.
  • Sovereign's Capital Management sold 40,974 NeoGenomics shares in Q4 2025, an estimated $316K.
  • Sovereign's Capital Management first reported a position in NeoGenomics in Q4 2024 and held it in 4 quarters.
  • Sovereign's Capital Management's NeoGenomics position peaked at $490K in Q4 2024.
  • 256 funds tracked by Wall St. Rank held NeoGenomics as of Q4 2025.

Based on Sovereign's Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.